510(k) Report

510(k) · Cleared

Cleared

Sera

K173567510(k) TraditionalCleared Feb 14, 201886-day reviewClass II21 CFR 874.1050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Interacoustics A/S · EWO Audiometer

Cleared on Feb 14, 2018 as substantially equivalent to K171506 (Maico Diagnostics GmbH, 2017) after an 86-day review. Its family tree reaches back 4 generations to 2006.

Decided
Feb 14, 2018
Review
86 days
Class
Class II
Product code
EWO
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K060539 (2006). 6 ancestors in all, the oldest K052562 (2005). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2009: 1 other ancestor2005: 1 other ancestorK060539 · DPOAE20 , Eclipse · Interacoustics A/S, Assens · 2006K103760 · TITAN · Interacoustics A/S · 2011K130795 · TITAN · Interacoustics A/S · 2013K171506 · Easyscreen · Maico Diagnostics GmbH · 20172005201020152020
  1. Root · 4 generations backK060539 DPOAE20 , EclipseInteracoustics A/S, Assens · 2006
  2. 3 generations backK103760 TITANInteracoustics A/S · 2011
  3. 2 generations backK130795 TITANInteracoustics A/S · 2013
  4. 1 generation backK171506 EasyscreenMaico Diagnostics GmbH · 2017
  5. This deviceK173567 SeraInteracoustics A/S · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K060539DPOAE20 , EclipseInteracoustics A/S, Assens2006—
−3K103760TITANInteracoustics A/S2011—
−2K130795TITANInteracoustics A/S2013—
−1K171506EasyscreenMaico Diagnostics GmbH2017—
0 (this device)K173567SeraInteracoustics A/S2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200510
200910
FIG. 1 — Lineage of K173567, 2006–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in EWO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new EWO device

  1. #1 K234095 OtoNova/OtoNova Proscore 9.4 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K171506Easyscreen
Summary page 4
…Class II Panel: Ear Nose & Throat / Neurology Classification Regulation: 874.1050/882.1900 Product Code: EWO/GWJ Predicate Device: easyScreen, cleared on 08/29/2017 via K171506 Device Description The device is audiometric equipment used for assisting in detecting of inner ear and auditory brainstem abno…
Maico Diagnostics GmbH2017—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 4.2 years on median.
  • None of the 6 ancestors has a recall.

How does its category compare?

All EWO devices

EWO Audiometer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · EWO

2in 2024

2007: 52008: 12009: 22010: 22011: 32012: 42013: 22014: 12015: 42017: 22018: 22019: 12022: 12023: 12024: 2
2007high 5 (2007) · low 0 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · EWO

173in 2015

2007: 69 days median2011: 151 days median2012: 137 days median2015: 173 days median
2007high 173 (2015) · low 69 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · EWO

4in 2023

2008: 12023: 4
2007high 4 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · EWO

13in 2025

2007: 12008: 12009: 12010: 42011: 22015: 12019: 62020: 72021: 32022: 62023: 32024: 22025: 13
2007high 13 (2025) · low 0 (2012)2025

MAUDE reports naming product code EWO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200756901
20081—11
20092—01
20102—04
2011315102
2012413700
20132—00
20141—00
2015417301
20160—00
20172—00
20182—00
20191—06
20200—07
20210—03
20221—06
20231—43
20242—02
20250—013
20260—0—

What is it indicated for?

The Sera™ with DPOAE is intended for use in the audiologic evaluation and documentation of ear disorders using Distortion Product Otoacoustic Emissions. The target population for Sera with DPOAE includes all ages. The Sera™ with TEOAE is intended for use in the audiologic evaluation and documentation of ear disorders using Transient Evoked Otoacoustic Emissions. The target population for Sera with TEOAE includes all ages. The Sera™ with ABRIS is intended…

Read the full statement (156 words)

The Sera™ with DPOAE is intended for use in the audiologic evaluation and documentation of ear disorders using

Distortion Product Otoacoustic Emissions. The target population for Sera with DPOAE includes all ages.

The Sera™ with TEOAE is intended for use in the audiologic evaluation and documentation of ear disorders using

Transient Evoked Otoacoustic Emissions. The target population for Sera with TEOAE includes all ages.

The Sera™ with ABRIS is intended for use in the audiologic evaluation and documentation of ear and nerve disorders

using auditory evoked potentials from the inner ear, the auditory nerve and the brainstem. The target population for Sera

with ABRIS is newborns.

The Sera™ System is to be used by trained personnel only, such as audiologists, ENT surgeons, doctors, hearing

healthcare professionals or personnel with a similar level of education. The device should not be used without the

necessary knowledge and training to understand its use and how results should be interpreted.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K173567: Sera.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K173567

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026